The Law Offices of Howard G. Smith Announces an Expanded Class Period in the Securities Class Action on Behalf of Juno Therap...
September 09 2016 - 11:31AM
Business Wire
Law Offices of Howard G. Smith announces that a new class
action lawsuit has been filed on behalf of investors who purchased
Juno Therapeutics, Inc. (“Juno” or the “Company”) (NASDAQ: JUNO)
securities between May 9, 2016 and July 7, 2016, inclusive
(the “Class Period”). Juno investors have until September
12, 2016 to file a lead plaintiff motion.
Investors suffering losses on their Juno investments are
encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email
to howardsmith@howardsmithlaw.com.
The complaint filed in this lawsuit alleges that throughout the
Class Period, defendants made misleading statements regarding the
safety and efficacy of Juno’s JCAR015, specifically failing to
disclose: (1) that in May 2016, a patient-participant in Juno’s
Phase II clinical trial of JCAR015 died; (2) that this death called
into question the efficacy and/or safety of JCAR015; (3) that, as a
result, FDA approval of JCAR015 would be delayed and/or denied; and
(4) that, as a result of the foregoing, Defendants’ statements
about Juno’s business, operations, and prospects, were false and
misleading and/or lacked a reasonable basis.
Following the Company’s disclosure of the adverse events and the
FDA’s clinical hold on JCAR015, Juno’s shares fell $13.01 per
share, or 31.8%, to close at $27.81 per share on July 8, 2016, on
unusually heavy trading volume.
If you purchased shares of Juno during the Class Period you may
move the Court no later than September 12, 2016 to
ask the Court to appoint you as lead plaintiff if you meet certain
legal requirements. To be a member of the Class you need not take
any action at this time; you may retain counsel of your choice or
take no action and remain an absent member of the Class. If you
wish to learn more about this action, or if you have any
questions concerning this announcement or your rights or interests
with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike,
Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160909005631/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
JUNO THERAPEUTICS, INC. (NASDAQ:JUNO)
Historical Stock Chart
From Mar 2024 to Apr 2024
JUNO THERAPEUTICS, INC. (NASDAQ:JUNO)
Historical Stock Chart
From Apr 2023 to Apr 2024